Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Financials 206 Healthcare 167 Information Technology 122 Industrials 60 Consumer Discretionary 31 Communication Services 24 Consumer Staples 15 Materials 14 Energy 8 Real Estate 7 Utilities 7

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 97 Pharmaceuticals 31 Healthcare Equipment & Supplies 19 Healthcare Providers & Services 9 Life Sciences Tools & Services 9 Health Care Technology 2
Curated industry list

Overvalued Stocks in Biotechnology on NASDAQ

Explore Overvalued Stocks in Biotechnology on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Achieve Life Sciences Inc (ACHV)
Fair Value-38.2% Downside Overvalued Analyst111.6% Upside Market Cap664.2 M P/E-13.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Anika Therapeutics Inc (ANIK)
Fair Value-26.3% Downside Overvalued Analyst9.4% Upside Market Cap262.4 M P/E-82.3x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Arrowhead Pharmaceuticals Inc (ARWR)
Fair Value-10.9% Downside Fair Analyst25.7% Upside Market Cap12.655 B P/E-40.8x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Celldex Therapeutics Inc (CLDX)
Fair Value-29.0% Downside Overvalued Analyst39.0% Upside Market Cap3.065 B P/E-11.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
ImmuCell Corporation (ICCC)
Fair Value-21.6% Downside Overvalued Market Cap100.1 M P/E-178.3x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Ionis Pharmaceuticals Inc (IONS)
Fair Value-12.9% Downside Fair Analyst64.9% Upside Market Cap9.152 B P/E-15.9x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Kazia Therapeutics Ltd ADR (KZIA)
Fair Value-20.1% Downside Overvalued Analyst132.6% Upside Market Cap140.7 M P/E-8.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Oruka Therapeutics Inc (ORKA)
Fair Value-37.1% Downside Overvalued Analyst52.5% Upside Market Cap5.918 B P/E-62.2x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Sellas Life Sciences Group Inc (SLS)
Fair Value-46.9% Downside Overvalued Analyst131.7% Upside Market Cap2.322 B P/E-79.2x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Tenax Therapeutics Inc (TENX)
Fair Value-34.0% Downside Overvalued Analyst170.5% Upside Market Cap791.6 M P/E-11.5x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Anixa Biosciences Inc (ANIX)
Fair Value-32.9% Downside Overvalued Analyst193.3% Upside Market Cap116 M P/E-11.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Aurinia Pharmaceuticals Inc (AUPH)
Fair Value-44.4% Downside Overvalued Analyst11.9% Upside Market Cap1.92 B P/E6.6x Yield0.0% HealthExcellent
  NASDAQ Featured in Overvalued Stocks Rapid Revenue Growth High-Growth Small-Cap Stocks Small-Cap Stocks
Caredx Inc (CDNA)
Fair Value-34.3% Downside Overvalued Analyst9.5% Upside Market Cap2.436 B P/E21.2x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
Cellectar Biosciences Inc (CLRB)
Fair Value-24.6% Downside Overvalued Analyst356.3% Upside Market Cap20.459 M P/E-1.0x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Crescent Biopharma Inc (CBIO)
Fair Value-24.2% Downside Overvalued Analyst94.0% Upside Market Cap701.1 M P/E-4.1x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Edesa Biotech Inc (EDSA)
Fair Value-28.3% Downside Overvalued Analyst215.9% Upside Market Cap47.661 M P/E-4.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Galectin Therapeutics Inc (GALT)
Fair Value-33.3% Downside Overvalued Analyst256.0% Upside Market Cap196.6 M P/E-7.7x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Palisade Bio Inc (PALI)
Fair Value-30.9% Downside Overvalued Analyst382.2% Upside Market Cap359.3 M P/E-15.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Precigen Inc (PGEN)
Fair Value-29.7% Downside Overvalued Analyst111.0% Upside Market Cap2.328 B P/E-6.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
TuHURA Biosciences Inc (HURA)
Fair Value-25.3% Downside Overvalued Analyst261.2% Upside Market Cap133.1 M P/E-4.3x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Uniqure NV (QURE)
Fair Value-19.5% Downside Overvalued Analyst57.5% Upside Market Cap3.03 B P/E-12.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Veracyte Inc (VCYT)
Fair Value-10.0% Downside Fair Analyst25.3% Upside Market Cap3.731 B P/E32.4x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Xencor Inc (XNCR)
Fair Value-16.8% Downside Fair Analyst42.8% Upside Market Cap1.477 B P/E-8.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
XTL Biopharmaceuticals Ltd ADR (XTLB)
Fair Value-46.8% Downside Overvalued Market Cap6.536 M P/E-8.6x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Aixcrypto Holdings Inc (AIXC)
Fair Value-30.3% Downside Overvalued Market Cap16.148 M P/E-0.7x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
AquaBounty Technologies Inc (AQB)
Fair Value-40.0% Downside Overvalued Market Cap4.684 M P/E-1.3x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Celcuity LLC (CELC)
Fair Value-42.7% Downside Overvalued Analyst76.0% Upside Market Cap4.51 B P/E-23.5x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Crispr Therapeutics AG (CRSP)
Fair Value-21.6% Downside Overvalued Analyst66.2% Upside Market Cap5.131 B P/E-11.2x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Denali Therapeutics Inc (DNLI)
Fair Value-38.3% Downside Overvalued Analyst40.5% Upside Market Cap3.836 B P/E-7.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Entera Bio Ltd (ENTX)
Fair Value-24.7% Downside Overvalued Analyst220.3% Upside Market Cap141.5 M P/E-11.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Forte Biosciences Inc (FBRX)
Fair Value-41.9% Downside Overvalued Analyst-3.7% Downside Market Cap1.872 B P/E-24.7x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
Fortress Biotech Inc Pref Series A (FBIOP)
Fair Value-0.6% Downside Fair Market Cap90.356 M P/E0.8x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Indaptus Therapeutics Inc (INDP)
Fair Value-33.6% Downside Overvalued Analyst651.9% Upside Market Cap154 M P/E-8.0x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
InflaRx N.V. (IFRX)
Fair Value-37.9% Downside Overvalued Analyst326.0% Upside Market Cap262.2 M P/E-5.3x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Lunai Bioworks Inc (LNAI)
Market Cap11.561 M P/E-0.1x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Natera Inc (NTRA)
Fair Value-39.1% Downside Overvalued Analyst3.0% Upside Market Cap39.411 B P/E-173.8x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks
Palvella Therapeutics Inc (PVLA)
Fair Value-26.0% Downside Overvalued Analyst48.8% Upside Market Cap2.19 B P/E-36.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Protagonist Therapeutics Inc (PTGX)
Fair Value-27.3% Downside Overvalued Analyst-2.9% Downside Market Cap8.734 B P/E-77.0x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Rein Therapeutics Inc (RNTX)
Fair Value-33.6% Downside Overvalued Analyst745.1% Upside Market Cap65.326 M P/E-1.2x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Spyre Therapeutics Inc (SYRE)
Fair Value-50.8% Downside Expensive Analyst13.4% Upside Market Cap9.228 B P/E-61.7x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Absci Corp (ABSI)
Fair Value-37.8% Downside Overvalued Analyst64.0% Upside Market Cap1.437 B P/E-12.0x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Candel Therapeutics Inc (CADL)
Fair Value-32.4% Downside Overvalued Analyst96.0% Upside Market Cap770.1 M P/E-14.1x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
Connect Biopharma Holdings Ltd (CNTB)
Fair Value-27.7% Downside Overvalued Analyst226.8% Upside Market Cap130.3 M P/E-2.1x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Cullinan Oncology LLC (CGEM)
Fair Value-17.7% Downside Fair Analyst79.5% Upside Market Cap1.079 B P/E-4.9x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Damora Therapeutics Inc (DMRA)
Fair Value-39.8% Downside Overvalued Analyst44.9% Upside Market Cap1.848 B P/E-8.1x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks Technical Strength Leaders Small-Cap Stocks
Design Therapeutics Inc (DSGN)
Fair Value-31.9% Downside Overvalued Analyst54.8% Upside Market Cap826.1 M P/E-12.0x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Dianthus Therapeutics Inc (DNTH)
Fair Value-27.2% Downside Overvalued Analyst14.3% Upside Market Cap6.035 B P/E-35.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Dyne Therapeutics Inc (DYN)
Fair Value-17.0% Downside Fair Analyst50.6% Upside Market Cap4.85 B P/E-9.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Erasca Inc (ERAS)
Fair Value-18.7% Downside Overvalued Analyst22.4% Upside Market Cap6.38 B P/E-23.3x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum
Exagen Inc (XGN)
Fair Value-44.0% Downside Overvalued Analyst48.2% Upside Market Cap155.8 M P/E-8.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Explore listed stocks on NASDAQ with company information and fair value data.